Inhibition of gastric cancer cell growth in vivo by overexpression of adeno-associated virus-mediated survivin mutant C84A

Oncology Research

Volumn 20, Issue 9, 2013, Pages 411-417

  Weng, Yuan ^a   Fei, Bojian ^a   Chi, Alfred L ^b   Cai, Ming ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b CHI Scientific Inc ^*  (United States)

Author keywords

Adeno associated virus (AAV); Apoptosis; Gastric cancer; Gene therapy; Survivin; Survivin mutant C84A

Indexed keywords

CASPASE 3; CYTOCHROME C; FLUOROURACIL; MUTANT PROTEIN; PARVOVIRUS VECTOR; SURVIVIN;

ADENO ASSOCIATED VIRUS; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL SURVIVAL; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; TUMOR XENOGRAFT; VIRUS RECOMBINANT;

EID: 84880309736     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13657689383094     Document Type: Article

References (34)

1. Kawasaki, H.; Toyoda, M.; Shinohara, H.; Okuda, J.; Watanabe, I.; Yamamoto, T.; Tanaka, K.; Tenjo, T.; Tanigawa, N. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91:2026-2032;2001.
2. Lee, G. H.; Joo, Y. E.; Koh, Y. S.; Chung, I. J.; Park, Y. K.; Lee, J. H.; Kim, H. S.; Choi, S. K.; Rew, J. S.; Park, C. S. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur. J. Gastroenterol. Hepatol. 18:957-963;2006.
3. Ambrosini, G.; Adida, C.; Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917-921;1997.
4. Tran, J.; Master, Z.; Yu, J. L.; Rak, J.; Dumont, D. J.; Kerbel, R. S. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad. Sci. USA. 99:4349-4354;2002.
5. Tamm, I.; Wang, Y.; Sausville, E.; Scudiero, D. A.; Vigna, N.; Oltersdorf, T.; Reed, J. C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:5315-5320;1998.
6. Juan, H. C.; Tsai, H. T.; Chang, P. H.; Huang, C. Y.; Hu, C. P.; Wong, F. H. Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability. Apoptosis 16:174-183;2011.
7. Zheng, W. E.; Chen, H.; Yuan, S. F.; Wu, L. L.; Zhang, W.; Sun, H. Y.; Chen, W. J. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxelbased chemotherapy in advanced gastric cancer. J. BUON. 17:284-290;2012.
8. Song, K. Y.; Jung, C. K.; Park, W. S.; Park, C. H. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn. J. Clin. Oncol. 39:290-296;2009.
9. Wang, T. T.; Qian, X. P.; Liu, B. R. Survivin: Potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J. Gastroenterol. 13:2784-2790;2007.
10. Ryan, B. M.; O'Donovan, N.; Duffy, M. J. Survivin: A new target for anticancer therapy. Cancer Treat. Rev. 35:553-562;2009.
11. Mesri, M.; Wall, N. R.; Li, J.; Kim, R. W.; Altieri, D. C. Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108:981-990;2001.
12. Grossman, D.; Kim, P. J.; Schechner, J. S.; Altieri, D. C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 98:635-640;2001.
13. Aspe, J. R.; Wall, N. R. Survivin-T34A: Molecular mechanism and therapeutic potential. Onco. Targets Ther. 3:247-254;2010.
14. Li, F.; Ling, X. Survivin study: An update of "what is the next wave"? J. Cell Physiol. 208:476-486;2006.
15. Tu, S. P.; Cui, J. T.; Liston, P.; Huajiang, X.; Xu, R.; Lin, M. C.; Zhu, Y. B.; Zou, B.; Ng, S. S.; Jiang, S. H.; Kung, X. H.; Wong, B. C. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Gastroenterology 128:361-375;2005.
16. Xue, Z.; Sun, P. H.; Zhu, L. M.; Jiang, S. H.; Qiao, M. M.; Chi, A. L.; Tu, S. P. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer. Oncol. Rep. 25:1039-1046;2011.
17. Miyachi, K.; Sasaki, K.; Onodera, S.; Taguchi, T.; Nagamachi, M.; Kaneko, H.; Sunagawa, M. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer 6:217-224;2003.
18. Vallbohmer, D.; Drebber, U.; Schneider, P. M.; Baldus, S.; Bollschweiler, E.; Brabender, J.; Warnecke-Eberz, U.; Monig, S.; Holscher, A. H.; Metzger, R. Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J. Surg. Oncol. 99:409-413;2009.
19. Tu, S. P.; Jiang, X. H.; Lin, M. C.; Cui, J. T.; Yang, Y.; Lum, C. T.; Zou, B.; Zhu, Y. B.; Jiang, S. H.; Wong, W. M.; Jiang, S. H.; Kung, X. H.; Wong, B. C. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 63:7724-7732;2003.
20. Brenes, O.; Arce, F.; Gatjens-Boniche, O.; Diaz, C. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Biomed. Pharmacother. 61:347-355;2007.
21. Carter, P. J.; Samulski, R. J. Adeno-associated viral vectors as gene delivery vehicles. Int. J. Mol. Med. 6:17-27;2000.
22. Enger, P. O.; Thorsen, F.; Lonning, P. E.; Bjerkvig, R.; Hoover, F. Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors. Hum. Gene Ther. 13:1115-1125;2002.
23. Li, F.; Ambrosini, G.; Chu, E. Y.; Plescia, J.; Tognin, S.; Marchisio, P. C.; Altieri, D. C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584;1998.
24. Li, F.; Ackermann, E. J.; Bennett, C. F.; Rothermel, A. L.; Plescia, J.; Tognin, S.; Villa, A.; Marchisio, P. C.; Altieri, D. C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1:461-466;1999.
25. Fulda, S.; Vucic, D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev. Drug Discov. 11:109-124;2012.
26. Kanwar, J. R.; Kamalapuram, S. K.; Kanwar, R. K. Targeting survivin in cancer: The cell-signalling perspective. Drug Discov. Today 16:485-494;2011.
27. Cai, X.; Ma, S.; Gu, M.; Zu, C.; Qu, W.; Zheng, X. Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagn. Pathol. 7:52-60;2012.
28. Wang, Z.; Fukuda, S.; Pelus, L. M. Survivin regulates the p53 tumor suppressor gene family. Oncogene 23:8146-8153;2004.
29. Zhang, T.; Fields, J. Z.; Opdenaker, L.; Otevrel, T.; Masuda, E.; Palazzo, J. P.; Isenberg, G. A.; Goldstein, S. D.; Brand, M.; Boman, B. M. Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development. Am. J. Pathol. 177:2816-2826;2010.
30. Fukuda, S.; Abe, M.; Onishi, C.; Taketani, T.; Purevsuren, J.; Yamaguchi, S.; Conway, E. M.; Pelus, L. M. Survivin selectively modulates genes deregulated in human leukemia stem cells. J. Oncol. 2011:946936-946942;2011.
31. Deveraux, Q. L.; Takahashi, R.; Salvesen, G. S.; Reed, J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-304;1997.
32. Verdecia, M. A.; Huang, H.; Dutil, E.; Kaiser, D. A.; Hunter, T.; Noel, J. P. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7:602-608;2000.
33. Mackenzie, M.; Spithoff, K.; Jonker, D. Systemic therapy for advanced gastric cancer: A clinical practice guideline. Curr. Oncol. 18:e202-2099;2011.
34. Lu, C. D.; Altieri, D. C.; Tanigawa, N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58:1808-1812;1998.